Novo’s New Pill Melts 5% Body Fat in 12 Weeks, And That’s Just the Start - Daily Base EN
Home » Novo’s New Pill Melts 5% Body Fat in 12 Weeks, And That’s Just the Start

Novo’s New Pill Melts 5% Body Fat in 12 Weeks, And That’s Just the Start

by Daniel
Novo Nordisk medicine

Novo Nordisk has become incredibly popular in the past few years for its “miracle” weight loss drugs. These drugs actually help people lose insane amounts of body weight. However, it does have a disadvantage. You have to inject the drug with needles, which some people really don’t like. But Novo has found a solution for it. Keep on reading to discover more about it.

Novo Nordisk is rewriting the weight-loss playbook with a wave of groundbreaking drugs. These drugs promise faster, more effective results, with fewer injections. The company is best known for Ozempic and Wegovy. However, the Danish pharmaceutical giant has now unveiled three new contenders that are already smashing expectations in clinical trials.

Among them, CagriSema, which is a once-weekly injectable, has turned heads with an average 20.4% body weight loss over 68 weeks. Even more impressive, nearly 1 in 5 participants dropped over 30% of their starting weight, setting a new bar in the GLP-1 drug space.

Novo’s new pill A Fat-Burning Pill That Actually Works

But the real disruption may come from amycretin, a next-gen drug that targets both hunger and metabolic rate. Unlike many weight-loss treatments, it comes in pill form. This way, they’re offering a more convenient option for patients wary of needles. In early trials, this oral version reduced 5.3% of body fat in just 12 weeks.

Novo Nordisk
Credit: SIC Noticias

Higher doses delivered via injection performed even better, with participants losing up to 24.3% of their total body weight. Side effects so far have been mostly limited to mild nausea and occasional vomiting, which are common issues for this drug class.

Eyes on the Market, Feet on the Gas

With Phase III trials approaching, Novo Nordisk isn’t just expanding its product line, It’s aiming to dominate the entire fat-loss market. They’re providing everything from injectables to pills. The company’s aggressive pipeline positions it ahead of competitors and could reshape how obesity is treated worldwide. These results signal more than a pharmaceutical win. They hint at a future where weight loss becomes safer, faster, and more accessible than ever before.

You may also like

Leave a Comment